No morbidity-mortality. Commentary.

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)7-8
Number of pages2
JournalDiabetic medicine : a journal of the British Diabetic Association
Volume19 Suppl 5
Publication statusPublished - Sep 2002
Externally publishedYes

Fingerprint

Adrenergic beta-Antagonists
Angiotensin Receptors
Atenolol
Losartan
Left Ventricular Hypertrophy
Diabetes Complications
Angiotensin II
Patient Selection
Diabetes Mellitus
Hypertension
Morbidity
Mortality

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

No morbidity-mortality. Commentary. / Malik, Rayaz.

In: Diabetic medicine : a journal of the British Diabetic Association, Vol. 19 Suppl 5, 09.2002, p. 7-8.

Research output: Contribution to journalComment/debate

@article{416a977d3b494473a4ebb5b247808c4f,
title = "No morbidity-mortality. Commentary.",
author = "Rayaz Malik",
year = "2002",
month = "9",
language = "English",
volume = "19 Suppl 5",
pages = "7--8",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - No morbidity-mortality. Commentary.

AU - Malik, Rayaz

PY - 2002/9

Y1 - 2002/9

UR - http://www.scopus.com/inward/record.url?scp=1842834251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842834251&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 12207801

AN - SCOPUS:1842834251

VL - 19 Suppl 5

SP - 7

EP - 8

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

ER -